Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Academy Sports (NASDAQ:ASO) is set to give its latest quarterly earnings report on Tuesday, 2022-06-07. Here's what investors need to know before the announcement. Analysts estimate that Academy Sports will report an earnings per share (EPS) of $1.41.

Benzinga

Death Cross Looms Over Vodafone Group Investors

If history is any guide, there may be trouble ahead for shares of Vodafone Group (NASDAQ:VOD). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Wednesday Is Your Last Chance To Buy Grindrod Shipping Hldgs Before The Dividend Payout

Wednesday marks the last chance for investors to receive the next dividend payout from Grindrod Shipping Hldgs (NASDAQ:GRIN).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Presidio Property Trust: Dividend Insights

Wednesday marks the last chance for investors to receive the next dividend payout from Presidio Property Trust (NASDAQ:SQFT).

Benzinga

Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection

Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic Hepatitis B Virus Infection

Benzinga

First US Bancshares's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from First US Bancshares (NASDAQ:FUSB).

Benzinga

Virginia National's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Virginia National (NASDAQ:VABK).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Value Stocks To Watch In The Healthcare Sector

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Looking At Lululemon Athletica's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Lululemon Athletica. Looking at options history for Lululemon Athletica (NASDAQ:LULU) we detected 11 strange trades.

Benzinga

Where GLOBALFOUNDRIES Stands With Analysts

Analysts have provided the following ratings for GLOBALFOUNDRIES (NASDAQ:GFS) within the last quarter:

Benzinga

Verint Systems's Earnings: A Preview

Verint Systems (NASDAQ:VRNT) is set to give its latest quarterly earnings report on Tuesday, 2022-06-07. Here's what investors need to know before the announcement. Analysts estimate that Verint Systems will report an earnings per share (EPS) of $0.47.

Benzinga

Pinduoduo Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Pinduoduo (NASDAQ:PDD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Amarin Outlines $100M Cost Saving Plan

Amarin Corporation plc (NASDAQ:AMRN) announced a comprehensive cost and organizational restructuring plan to reduce operating costs by approximately $100 million over the next 12 months. The restructuring will enable Amarin to maintain a positive contribution margin in the U.S. while investing in its European market launches and global expansion for Vascepa/Vazkepa. The majority…

Benzinga

Why AeroClean Shares Are Jumping Today

AeroClean Technologies Inc's (NASDAQ:AERC) Pūrgo technology has secured U.S. FDA 510(k) clearance, classifying it as a Class II Medical Device. The clearance was granted following examination of the patented Pūrgo device, which utilizes patented germicidal UV-C LED air purification technology that has been proven to eliminate 99.99% of harmful airborne microorganisms, including…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,200 Today

Seagen (NASDAQ:SGEN) has outperformed the market over the past 5 years by 5.77% on an annualized basis producing an average annual return of 17.01%. Currently, Seagen has a market capitalization of $26.17 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Upgrades

Benzinga

Arcturus Therapeutics's Return On Capital Employed Overview

Benzinga Pro data, Arcturus Therapeutics (NASDAQ:ARCT) reported Q1 sales of $5.24 million. Earnings fell to a loss of $51.17 million, resulting in a 32.35% decrease from last quarter.

Benzinga

Elon Musk Sends Letter To Twitter: Here's Why The Social Media Stock Is Sliding

Twitter Inc (NYSE: TWTR) shares are trading lower Monday after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk indicated that the social media company breached obligations under the merger agreement

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Enanta Pharmaceuticals's Return On Capital Employed Overview

Benzinga Pro data, Enanta Pharmaceuticals (NASDAQ:ENTA) reported Q2 sales of $18.72 million. Earnings fell to a loss of $33.59 million, resulting in a 11.55% decrease from last quarter.

Benzinga

Looking Into Infrastructure and Energy's Return On Capital Employed

Infrastructure and Energy (NASDAQ:IEA) brought in sales totaling $360.10 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 185.52%, resulting in a loss of $27.07 million.

Benzinga

SRAX Shares Trade Lower On Q4 Miss

SRAX, Inc (NASDAQ:SRAX) reported fourth-quarter FY21 Sequire revenue growth of 170% year-on-year to $9.6 million, missing the consensus of $10.2 million. The continued adoption of its SaaS platform Sequire drove the increase. SRAX held $1.35 million in cash and equivalents. Outlook: SRAX sees Q1 FY22 revenue of $11.5 million in line with the consensus…

Benzinga

Y-mAbs Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Y-mAbs Therapeutics's (NASDAQ:YMAB) reported sales totaled $10.49 million. Despite a 23.92% increase in earnings, the company posted a loss of $28.07 million.

Benzinga

Verra Mobility Earnings Perspective: Return On Invested Capital

Pulled from Benzinga Pro data, Verra Mobility (NASDAQ:VRRM) showed a loss in earnings since Q4, totaling $10.04 million. Sales, on the other hand, increased by 0.24% to $170.38 million during Q1.

Benzinga

ShockWave Medical's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, ShockWave Medical (NASDAQ:SWAV) earned $14.52 million, a 12.2% increase from the preceding quarter. ShockWave Medical also posted a total of $93.63 million in sales, a 11.22% increase since Q4.

Benzinga

Thomas Gayner Purchases 5,000 Shares of Cable One (CABO) For Markel

One of the patterns we like to see with insider buying is a long-serving Director of the company purchasing shares opportunistically. If that Director also happens to have an investing background, we like it even better. The cherry on the top is the company also buying back stock on the…

1 … 461 462 463 464

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.